Showing results (1771-1780 of 1,938) with videos related to

Sort By:
Pageof 194
Elife|January 21, 2020
The kinesin-5 tail domain directly modulates the mechanochemical cycle of the motor domain for anti-parallel microtubule slidingTatyana Bodrug, Elizabeth M Wilson-Kubalek, Stanley Nithianantham, et al.
Cancers|December 5, 2019
Analysis of the Whole-Exome Sequencing of Tumor and Circulating Tumor DNA in Metastatic MelanomaRussell J Diefenbach, Jenny H Lee, Dario Strbenac, et al.
JAMA Network Open|March 20, 2024
Adrenal-Permissive Germline HSD3B1 Allele and Prostate Cancer OutcomesRana R McKay, Tyler J Nelson, Meghana S Pagadala, et al.
Annals of Surgical Oncology|May 27, 2024
Impact of an Online Risk Calculator for Sentinel Node Positivity on Management of Patients with T1 and T2 MelanomasAlec A Winder, Zoe Boyer, Sydney Ch'ng, et al.
Annals of Surgical Oncology|December 22, 2019
Regional Node Basin Recurrence in Melanoma Patients: More Common After Node Dissection for Macroscopic Rather than Clinically Occult Nodal DiseaseAbhineet Uppal, Stacey Stern, John F Thompson, et al.
Oncotarget|October 22, 2014
TRIM16 inhibits proliferation and migration through regulation of interferon beta 1 in melanoma cellsSelina K Sutton, Jessica Koach, Owen Tan, et al.
The Journal of Investigative Dermatology|August 31, 2012
BRAF mutation, NRAS mutation, and the absence of an immune-related expressed gene profile predict poor outcome in patients with stage III melanomaGraham J Mann, Gulietta M Pupo, Anna E Campain, et al.
Cell|February 11, 1998
Importance of the intracellular domain of NR2 subunits for NMDA receptor function in vivoR Sprengel, B Suchanek, C Amico, et al.
CA: a Cancer Journal for Clinicians|October 14, 2017
Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manualJeffrey E Gershenwald, Richard A Scolyer, Kenneth R Hess, et al.
Pageof 194